Company news
Spermosens Ab (NGM:SPERM) news
Spermosens Ab news releases on 6ix. Latest, May 7, 2026: Spermosens secures SEK 4.85 million capital facility to support development and commercialization
Press releases & updates
Spermosens secures SEK 4.85 million capital facility to support development and commercialization
May 7, 2026
Spermosens AB (publ) INTERIM REPORT JANUARY - MARCH 2026
May 7, 2026
Spermosens completes development of JUNO-Checked Generation 3 and initiates clinical validation study
April 8, 2026
Spermosens AB (publ)YEAR-END REPORT JANUARY - DECEMBER 2025
February 11, 2026
Spermosens announces outcome of exercise of warrants series TO 4
December 8, 2025
Spermosens announces last day of trading for warrants of series TO 4
November 24, 2025
Spermosens AB (publ) INTERIM REPORT JANUARY - SEPTEMBER 2025
November 12, 2025
Spermosens receives patent approval in Israel
November 4, 2025
Spermosens receives patent approval in Mexico
November 3, 2025